title: New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment.
authors.affiliation: Department of Psychiatry, Massachusetts General Hospital, Boston 02114, USA. goldstle@helix.mgh.harvard.edu
authors.forename: L E
authors.initials: LE
authors.lastname: Goldstein
authors.forename: J
authors.initials: J
authors.lastname: Sporn
authors.forename: S
authors.initials: S
authors.lastname: Brown
authors.forename: H
authors.initials: H
authors.lastname: Kim
authors.forename: J
authors.initials: J
authors.lastname: Finkelstein
authors.forename: G K
authors.initials: GK
authors.lastname: Gaffey
authors.forename: G
authors.initials: G
authors.lastname: Sachs
authors.forename: T A
authors.initials: TA
authors.lastname: Stern
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000188:drug therapy; D016883:Diabetic Ketoacidosis / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D008875:Middle Aged; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine